(WEYS) Weyco - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US9621491003

WEYS: Footwear, Shoes, Boots, Sandals, Leather, Casual, Dress

Weyco Group, Inc. operates as a footwear designer and distributor, primarily catering to men, women, and children. The company is structured into two main segments: North American Wholesale Operations and North American Retail Operations. Its product portfolio includes mid-priced leather dress shoes, casual footwear made from leather and synthetic materials, and outdoor footwear such as boots, shoes, and sandals. These products are marketed under well-known brands including Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company distributes its products through various channels, including wholesale to footwear retailers, department stores, specialty stores, and e-commerce platforms in the U.S. and Canada. Additionally, Weyco manages its own e-commerce platform and operates brick-and-mortar retail stores across the U.S. The company also engages in licensing agreements, allowing third parties to sell branded apparel, accessories, and specialty footwear. Geographically, Weyco operates in the U.S., Canada, Australia, and South Africa. Originally established as Weyenberg Shoe Manufacturing Company in 1906, the company rebranded as Weyco Group, Inc. in April 1990 and is headquartered in Milwaukee, Wisconsin.

Over the next three months, Weyco Group, Inc. (NASDAQ:WEYS) is expected to experience moderate volatility with potential upside. Technically, the stock is trading near its 20-day (35.23) and 50-day (36.00) simple moving averages, which could act as resistance levels. A breakout above these levels may trigger a rally toward the 38.00 mark. Conversely, the 200-day SMA (33.43) and the ATR (1.11) suggest that the stock could face support at 32.50 if it corrects. On the fundamental side, the company’s P/E ratio of 11.18 indicates reasonable valuation, while the price-to-book ratio of 1.36 reflects moderate asset valuation. The return on equity (RoE) of 11.18% signals efficient profitability. Overall, the stock is likely to trade in a range-bound manner, with potential for a slight upward movement if it surpasses the 20-day and 50-day SMAs.

Additional Sources for WEYS Stock

WEYS Stock Overview

Market Cap in USD 302m
Sector Consumer Cyclical
Industry Footwear & Accessories
GiC Sub-Industry Distributors
IPO / Inception 1990-03-26

WEYS Stock Ratings

Growth 5y 71.0%
Fundamental 25.7%
Dividend 61.1%
Rel. Strength Industry -0.87
Analysts -
Fair Price Momentum 30.45 USD
Fair Price DCF 87.76 USD

WEYS Dividends

Dividend Yield 12m 3.25%
Yield on Cost 5y 6.08%
Annual Growth 5y 1.42%
Payout Consistency 98.8%

WEYS Growth Ratios

Growth Correlation 3m -25.1%
Growth Correlation 12m 85.4%
Growth Correlation 5y 95.3%
CAGR 5y 12.24%
CAGR/Max DD 5y 0.34
Sharpe Ratio 12m -0.53
Alpha -0.92
Beta 0.99
Volatility 35.48%
Current Volume 19.9k
Average Volume 20d 10.9k
What is the price of WEYS stocks?
As of March 12, 2025, the stock is trading at USD 30.20 with a total of 19,856 shares traded.
Over the past week, the price has changed by -7.79%, over one month by -17.73%, over three months by -10.15% and over the past year by +9.17%.
Is Weyco a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Weyco is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 25.73 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of WEYS as of March 2025 is 30.45. This means that WEYS is currently overvalued and has a potential downside of 0.83%.
Is WEYS a buy, sell or hold?
Weyco has no consensus analysts rating.
What are the forecast for WEYS stock price target?
According to ValueRays Forecast Model, WEYS Weyco will be worth about 34.7 in March 2026. The stock is currently trading at 30.20. This means that the stock has a potential upside of +14.74%.
Issuer Forecast Upside
Wallstreet Target Price 26 -13.9%
Analysts Target Price 26 -13.9%
ValueRay Target Price 34.7 14.7%